BIOMAT Database Logo BIOMAT Database Logo

Novel insights into biomarkers of progression in Desmoid tumor. 2023

Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
Department of Hernia and Abdominal Wall Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, China.

Desmoid tumor (DT) is a rare neoplasm characterized by the proliferation of myofibroblastic cells that infiltrates and invades adjacent tissues. Due to its locally aggressive and recurrent nature, DT often causes local symptoms and can be challenging to manage clinically. Therefore, identifying biomarkers that can predict the progression of DT and guide treatment decisions is critical. This review summarizes several biomarkers that have been implicated in active surveillance (AS) and the prediction of postoperative recurrence and attempts to elucidate their underlying mechanisms. Some of these novel markers could provide prognostic value for clinicians, and ultimately help facilitate optimal and accurate therapeutic decisions for DT.

UI MeSH Term Description Entries

Related Publications

Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.
December 2023, MedComm,
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
Molecular insights into desmoid tumors.
October 2017, Oncotarget,
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
Novel insights into extrachromosomal DNA: redefining the onco-drivers of tumor progression.
October 2020, Journal of experimental & clinical cancer research : CR,
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
A Mesenteric Desmoid Tumor with Rapid Progression.
January 2017, Internal medicine (Tokyo, Japan),
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
NAFLD in 2017: Novel insights into mechanisms of disease progression.
February 2018, Nature reviews. Gastroenterology & hepatology,
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics.
January 2022, Frontiers in cardiovascular medicine,
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
Novel insights into biomarkers associated with renal cell carcinoma.
July 2018, Oncology letters,
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
Desmoid tumor: a disease opportune for molecular insights.
January 2008, Histology and histopathology,
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
Cytoglobin in tumor hypoxia: novel insights into cancer suppression.
July 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Baiqi Liu, and Zefang Sun, and Rui Zhou, and Dingcheng Shen, and Shuai Zhu, and Lu Chen, and Gengwen Huang
[Desmoid tumor - transformation into fibrosarcoma (author's transl)].
January 1981, Dermatologica,
Copied contents to your clipboard!